Evidence map›Paper›PMID 42352525›Full record

ArticleCancers2026

MerTK Is Regulated by Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2 in Colon Cancer Cells.

Gargi Sivaram, Srijana Upadhyay, Sarah Kakwan, Ahmed Uosef, Maen Abdelrahim, Arafat Rahman Oany, Evan Farkas, Stephen Safe

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gargi SivaramDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0003-4278-7019
Srijana UpadhyayDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0001-5236-3485
Sarah KakwanDepartment of Biomedical Sciences, Texas A&M University, College Station, TX 77843, USA.ORCID 0009-0009-3446-4851
Ahmed UosefTransplant Immunology, The Houston Methodist Research Institute, Houston, TX 77030, USA.ORCID 0000-0003-0440-2739
Maen AbdelrahimDepartment of Medical Oncology, Houston Methodist Neal Cancer Center, Houston, TX 77030, USA.
Arafat Rahman OanyDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0003-2228-457X
Evan FarkasDepartment of Veterinary Physiology and Pharmacology, Texas A&M University, College Station, TX 77843, USA.ORCID 0009-0006-2724-5667
Stephen SafeDepartment of Biochemistry and Biophysics, Texas A&M University, College Station, TX 77843, USA.ORCID 0000-0002-2115-3060

Funding

NIH HHS R01-CA269580Syd Kyle Chair Endowment XXTexas A&M AgriLife XX
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

colon cancerDIM-3,5 ligandsMerTKNR4A1NR4A2transcriptional regulation

Identifiers

PMID42352525
PMCPMC13296424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.